Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by jopatcloon Nov 11, 2024 2:27pm
60 Views
Post# 36307011

Us2.ai has a feature that leverages the speed of our AI,

Us2.ai has a feature that leverages the speed of our AI, Interesting see *like this Gary Dunn View Gary Dunn’s profile Out of network
Assistant Director, Imaging at Duke Clinical Research Institute
&
*Like this Hannah Crane View Hannah Crane’s profile Out of network
Clinical Applications Specialist & Cardiac Sonographer ( Ventripoint ) on post 
Was chatting with some hashtagecho enthusiasts recently and realized I should share a very useful and powerful application of hashtagAI in hashtagechocardiography: longitudinal comparison of multiple echos of a single patient can offer significant clinical benefit but is often too time consuming to be practical. Us2.ai has a feature that leverages the speed of our AI, analyzing multiple patient echos in ~2-mins, then graphing each parameter longitudinally and presenting the annotations side by side (including GLS), removing operator variability and bias in the process (our AI is 100% reproducible).

Imagine analyzing 3-4 echos of a patient in just a few minutes with zero human intervention and zero clicks required :-)

<< Previous
Bullboard Posts
Next >>